latest news in Biotech

MoonLake Investors Face Critical Deadline Following 90% Share Value Collapse

MoonLake Investors Face Critical Deadline Following 90% Share Value Collapse

New York, Saturday, 13 December 2025.
MoonLake investors face a December 15 deadline to join a class action lawsuit after failed technology claims triggered a catastrophic 90% stock collapse, wiping out nearly all value overnight.